"SCIENCE DOESN'T move in a straight line," says Stéphane Bancel, "especially with cutting-edge science that no human has done before you." The 50-year-old CEO of the biotech company Moderna is familiar with circuitous journeys and unexpected turns of fate.
Founded in 2010 by a group of influential scientists from Harvard and MIT, Moderna spent its first decade pursuing research into the then-novel idea of using mRNA as a platform to create vaccines and drugs that essentially manufacture themselves in a patient's body. But by early 2020, it still didn't have a single product on the market. It did, however, have six vaccines in Phase 1 trials, and was working on one against MERS, a type of coronavirus. And it had built a 150,000-square-foot facility in the Boston suburb of Norwood, ready to mass-produce mRNA vaccines. Just in case.
When the genetic sequence of a novel coronavirus from China was made public on January 11, 2020, Moderna was ready. It tapped its mRNA platform to develop a new vaccine candidate, and on December 18, 2020, it obtained FDA emergency use authorization (EUA) for a COVID-19 vaccine, marking one of the shortest vaccine-development cycles ever. (The FDA issued an EUA for the Pfizer-BioNTech COVID-19 vaccine just one week earlier.) The company produced billions of doses over the next couple of years, driving annual revenue from $60 million in 2019 to $18.4 billion last year.
But as demand for COVID-19 booster shots wanes-and with a flurry of competitors now developing their own mRNA vaccines and drugs-Moderna finds itself once again seeking its way. For investors, who sent the company's market cap skyrocketing from roughly $6 billion in 2019 to $196 billion at its peak in August 2021 (it's now back at a more earthbound $50 billion), the company needs to prove that it's not a one-shot wonder, or even "just" a vaccine maker.
This story is from the Summer 2023 edition of Fast Company.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the Summer 2023 edition of Fast Company.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
The World's 50 Most Innovative Companies - CAMPUS
FOR CREATING A NATIONAL ONLINE COMMUNITY COLLEGE
The World's 50 Most Innovative Companies - SOL DE JANEIRO
FOR DROPPING NEW FRAGRANCES AT AN INTOXICATING PACE
The World's 50 Most Innovative Companies - VANTA
FOR OFFER ING STARTUPS TOOLS TO TRUST BUT VERIFYIN THE AGE OF AI
The World's 50 Most Innovative Companies - PERPLEXITY
FOR LOCATING THE ANSWER TO THE PERENNIAL PROBLEMS OF WEB SEARCH
The World's 50 Most Innovative Companies - THE POWER BROKER
ITS CHIPS SPARKED THE AI REVOLUTION. NOW NVIDIA IS PUTTING THE TECH TO WORK ACROSS INDUSTRIES.
The World's 50 Most Innovative Companies - NATIONAL WOMEN'S SOCCER LEAGUE
FOR RESETTING THE VALUE OF WOMEN'S SPORTS
08 FOR WHOM THE BELL TOLLS
WITH A NEW CEO BEHIND THE COUNTER. TACO BELL IS FOLLOWING A FRESH STRATEGY FOR GLOBAL CULTURAL DOMINATION. ONE TACO TUESDAY AT A TIME.
Reimagining the ways we work and meet
As business leaders rethink their real estate footprint, they're embracing smaller, high-quality, amenity-rich spaces that are more focused on human connection.” In other words, Convene.
10 Trend
From the Most Innovative Companies | Plus 606 Honorees From Advertising to Video
The World's 50 Most Innovative Companies
"The 1920s, water went into a generator, and DC Power came out. Now electrons go into a generator, and intelligence comes out."